Login / Signup
Lucile Vanhersecke
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Epidermal Growth Factor Receptor
Ejection Fraction
Peritoneal Dialysis
Advanced Non Small Cell Lung Cancer
Top Venues
Clinical cancer research : an official journal of the American Association for Cancer Research
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Alban Bessede
,
Florent Peyraud
,
Benjamin Besse
,
Sophie Cousin
,
Mathilde Cabart
,
François Chomy
,
Christophe Rey
,
Oren Lara
,
Ophélie Odin
,
Imane Nafia
,
Lucile Vanhersecke
,
Fabrice Barlesi
,
Jean-Philippe Guégan
,
Antoine Italiano
TROP2 is associated with primary resistance to immune checkpoint inhibition in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research
(2023)